Wuxi AppTec Co Ltd (WUXAY)
5.07
-0.38
(-6.97%)
USD |
OTCM |
May 17, 15:52
Wuxi AppTec Enterprise Value: 13.50B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 13.50B |
| May 16, 2024 | 14.61B |
| May 15, 2024 | 14.08B |
| May 14, 2024 | 14.46B |
| May 13, 2024 | 13.06B |
| May 10, 2024 | 13.29B |
| May 09, 2024 | 12.41B |
| May 08, 2024 | 12.42B |
| May 07, 2024 | 12.47B |
| May 06, 2024 | 13.00B |
| May 03, 2024 | 12.62B |
| May 02, 2024 | 13.50B |
| May 01, 2024 | 11.75B |
| April 30, 2024 | 11.75B |
| April 29, 2024 | 11.68B |
| April 26, 2024 | 11.56B |
| April 25, 2024 | 11.05B |
| April 24, 2024 | 11.33B |
| April 23, 2024 | 11.41B |
| April 22, 2024 | 11.21B |
| April 19, 2024 | 11.21B |
| April 18, 2024 | 11.88B |
| April 17, 2024 | 11.88B |
| April 16, 2024 | 10.65B |
| April 15, 2024 | 11.39B |
| Date | Value |
|---|---|
| April 12, 2024 | 11.41B |
| April 11, 2024 | 11.88B |
| April 10, 2024 | 12.03B |
| April 09, 2024 | 12.79B |
| April 08, 2024 | 12.35B |
| April 05, 2024 | 11.78B |
| April 04, 2024 | 12.76B |
| April 03, 2024 | 12.57B |
| April 02, 2024 | 12.53B |
| April 01, 2024 | 12.79B |
| March 31, 2024 | 12.51B |
| March 28, 2024 | 12.66B |
| March 27, 2024 | 12.51B |
| March 26, 2024 | 13.14B |
| March 25, 2024 | 13.38B |
| March 22, 2024 | 13.90B |
| March 21, 2024 | 13.83B |
| March 20, 2024 | 13.51B |
| March 19, 2024 | 13.61B |
| March 18, 2024 | 14.66B |
| March 15, 2024 | 14.14B |
| March 14, 2024 | 15.53B |
| March 13, 2024 | 18.47B |
| March 12, 2024 | 17.98B |
| March 11, 2024 | 17.38B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.65B
Minimum
Apr 16 2024
67.42B
Maximum
Dec 01 2021
33.58B
Average
32.30B
Median
Aug 29 2023
Enterprise Value Benchmarks
| WuXi Biologics (Cayman) Inc | 6.730B |
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 32.35M |
| Zai Lab Ltd | 1.313B |
| Gracell Biotechnologies Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 271.44M |
| Revenue (Quarterly) | 1.116B |
| Total Expenses (Quarterly) | 836.85M |
| EPS Diluted (Quarterly) | 0.0922 |
| Gross Profit Margin (Quarterly) | 38.13% |
| Profit Margin (Quarterly) | 24.33% |
| Earnings Yield | 8.79% |
| Operating Earnings Yield | 10.58% |
| Normalized Earnings Yield | 9.317 |